Congrats to Drs. Derefinko and Sumida for being named the grant recipients for TN-CTSI's Pilot Translational and Clinical Studies Program. #uthsc#uthscresearch#uthscmedicine
https://t.co/Rm8dXsx5YC
Today! @UTHSCMedicine will host its second Addiction Symposium from 12 to 2 p.m. CDT. The online symposium is free and open to health care practitioners and the public. The symposium will be via Zoom and is accredited for 2 hours of CME credits. https://t.co/9tNa582PE4
Getting ready to launch our newest project on stigma reduction in African American communities regarding Opioid Use Disorder! @KarenDerefinko@JgmurphyJim https://t.co/3QBhxOViaa
Childhood smoking and chronic #depression are important correlates of young adult #opioid use. Both are associated with impaired reward system functioning, which may increase young adults' vulnerability to opioid-associated euphoria #opioidcrisis https://t.co/KACtpAVCNZ
We were featured in this month’s NCCIH Director’s Newsletter as one of eight projects working on stigma associated with opioid use disorder! You can read more about how stigma affects the opioid crisis here:
https://t.co/CyMxI8PSNG
Today is International Overdose Awareness Day. We are raising awareness, reducing stigma of drug-related deaths and commemorating those who have been lost to drug overdose. To learn more go to: https://t.co/8jF33BGm3A and https://t.co/LxF8Lodxyh.
Just an incredible study in @AnnalsofIM on opioid prescribing after childbirth
Opioids started after *59%* of vaginal deliveries and 91% of C-sections
https://t.co/GwZmlyt0B0
Richard Hayward and John Woods: "We must not allow social distancing to lead to dangerous social isolation. The recovery community is aware of the challenges created by COVID-19, and making sure resources are available for those who need them. " https://t.co/E1yqwjQ25b
Happy #ClinicalTrialsDay! Thank you to all the clinical researchers, administrators, and funding agencies that make innovation in clinical care and public health possible.
A NIDA-funded study indicates that neonatal abstinence syndrome (#NAS) in the US has reached a plateau after increasing for nearly 20 years.
https://t.co/AFCeTzrojT
Comparative effectiveness study with 41k insured people w OUD finds only buprenorphine/methadone associated with reduced #overdose at 3 & 12 mos; longer treatment assoc w lowest OD risk #VisualAbstract https://t.co/e6cHMyjCrc @DrSarahWakeman @MDaware
Our April issue is now online, and we have new studies on sexually transmitted infections, opioids, and transgender health from @KarenDerefinko @gregcalip @DrShannaK @KinneyMarea @DrMikeLindsey https://t.co/FIYOzjTtSF
.@UT_President: Last year we hosted the first Summit for Opioid Addition and Response with over 700 attendees. We plan on doing it again this year, with taskforces across the System working diligently to make this event effective.
Adverse childhood experiences shaped Charlie Caswell’s life, but he has been able to overcome the psychological damage that comes with ACEs and is helping others: https://t.co/c06Uxbfeko
My colleague @LauraFahertyMD has cared for many babies w/ neonatal abstinence syndrome.
In this op-ed, she explains research-based reasons why policies that punish women for substance use aren't helpful for mothers or infants. https://t.co/FATUv4pgQz
Thanks to the efforts of Generation Rx, a @UTPharmacy student organization at #UTHSC dedicated to educating the general public about medication safety, a prescription drug drop box is now on campus to properly dispose of unwanted or used medications.
https://t.co/3S4tgGbg1E